Pfizer to buy cancer drug maker Seagen for $43B



Pfizer Inc. announced on Monday that it entered a definitive agreement to buy transformative cancer medicines company Seagen Inc, for $43 billion, or $229 per share in cash.

“Pfizer is deploying…